Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 59,203 | 55,312 | 54,264 | 54,561 | 53,898 |
| Gross Profit | 59,203 | 55,312 | 54,264 | 54,561 | 53,898 |
| Operating Expenses | 32,024 | 30,968 | 29,835 | 27,688 | 27,695 |
| Operating Income | 27,179 | 24,344 | 24,429 | 26,873 | 26,203 |
| Interest Expense | 9,265 | 8,883 | 8,795 | 9,095 | 9,546 |
| Other Income | 1 | 1 | 4 | -86 | 0 |
| Pre-tax Income | 17,915 | 15,462 | 15,638 | 17,692 | 16,657 |
| Income Tax | 1,482 | 1,968 | 1,407 | 1,507 | 1,320 |
| Net Income Continuous | 16,433 | 13,494 | 14,231 | 16,185 | 15,337 |
| Minority Interests | 38 | 48 | -40 | N/A | N/A |
| Net Income | $16,395 | $13,446 | $14,271 | $15,591 | $15,337 |
| EPS Basic Total Ops | 0.78 | 0.61 | 0.64 | 0.71 | 0.69 |
| EPS Basic Continuous Ops | 0.78 | 0.62 | 0.64 | 0.73 | 0.69 |
| EPS Diluted Total Ops | 0.77 | 0.60 | 0.63 | 0.68 | 0.68 |
| EPS Diluted Continuous Ops | 0.77 | 0.60 | 0.63 | 0.71 | 0.68 |
| EBITDA(a) | $48,134 | $44,314 | $44,005 | $45,893 | $44,641 |